The Ministry of Health’s Continued Enhanced Surveillance, Confirms One Additional Case of Malaria
Port of Spain, April 7, 2025: As the Ministry of Health (MOH) continues its enhanced surveillance for Malaria, one additional case has been confirmed in South Trinidad.
This brings to eight, the total number of Malaria cases detected for 2025.
Medical Product Alert – Falsified OXYCONTIN 80mg
Port of Spain, April 08, 2025: The Ministry of Health (MoH), via its Drug Inspectorate Division advises of the WHO Medical Product Alert of one batch of falsified (contaminated) OXYCONTIN 80mg. OXYCONTIN (oxycodone hydrochloride) is a semi-synthetic opioid indicated for the treatment of moderate to severe pain.
Fourteen Countries Gather in Trinidad and Tobago to Strengthen Drug Policies and Community-Based Interventions
Port of Spain, April 2nd, 2025: Fifty experts from health and drug administrations across the European Union, Latin America and the Caribbean participated in a three-day meeting at the Brix Hotel, Port of Spain, to enhance drug-related policies and expand community-based interventions.
The Ministry of Health Investigates Five Cases of Malaria
Port of Spain, April 2, 2025: The Ministry of Health is currently investigating a cluster of Malaria cases in South Trinidad. As of today, April 2, 2025, five cases have been confirmed, including the primary source, which brings the total number of cases for 2025 to five (5); as there were no other confirmed cases for 2025.
Port of Spain, February 26, 2025: TheMinistry of Health, in partnership with the Pan American Health Organization (PAHO), hosted a WHO QualityRights Train the Trainer Workshop, aimed at enhancing mental health care in Trinidad and Tobago.
The workshop provided knowledge to support attitudinal and practical change that is rooted in principles of human rights and recovery. The goal is to improve patient experiences at all mental health services across Trinidad and Tobago.
Port of Spain, February 21, 2025: The Ministry of Health (MoH), via its Chemistry, Food and Drugs Division advises of the voluntary recall of one lot of ChloraPrep™ Clear 1 mL Applicator. These applicators are used for the preparation of a patient’s skin prior to surgery and helps to reduce bacteria that can potentially cause skin infection.
Port of Spain, January 29, 2025: The Ministry of Health (MOH) notes with concern the editorial published in the Express newspaper on January 29, 2025, regarding the drug “Ozempic”. The Ministry wishes to categorically state that there are no bureaucratic delays (“red tape”) preventing the approval of “Ozempic” or any other drug.
